Equity Upgrades and Downgrades December 22nd

The DJIA closed up 61 points at 12,169, the S&P 500 Index closed up 10 points at 1,254 and the Nasdaq finished up 21 points at 2,599 in today’s trading. Wall Street brokerage analysts provided the following upgrade and downgrade ratings on these companies:

Upgrades

Potash (NYSE:POT): RBC Capital Mkts upgraded its rating on this company from Sector Perform to Outperform and changed its price target from $58 to $50. About the company: Potash Corporation of Saskatchewan Inc. produces potash, phosphate, and nitrogen to the agricultural and industrial industries worldwide. The Company conducts operations in Canada, Chile, the United States, Brazil, and Trinidad. Get the most recent company news and stock data here >>

Bill Barrett (NYSE:BBG): Stifel Nicolaus upgraded its rating on this company from Hold to Buy and changed its price target to $43. About the company: Bill Barrett Corporation is an independent oil and gas company focused on natural gas exploration and development in the Rocky Mountain region of the United States. Get the most recent company news and stock data here >>

TIBCO Software (NASDAQ:TIBX): Mizuho upgraded its rating on this company from Neutral to Buy. About the company: TIBCO Software Inc. provides electronic business infrastructure software products that enable business-to-business, business-to-consumer, and business-to-employee solutions. The Company’s software products enable businesses to link internal operations, business partners, and customer channels in real time. Get the most recent company news and stock data here >>

VMware (NYSE:VMW): Wunderlich upgraded its rating on this company from Hold to Buy and changed its price target to $95. About the company: VMware, Inc. provides virtualization solutions from the desktop to the data center. The Company’s solution products addresses a range of IT problems, which includes cost and operational inefficiencies, business continuity, software lifecycle management and desktop management. Get the most recent company news and stock data here >>

Zimmer Hldgs (NYSE:ZMH): Mizuho upgraded its rating on this company from Neutral to Buy and changed its price target from $53 to $62. About the company: Zimmer Holdings, Inc. designs, develops, manufactures, and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Zimmer markets its products in the United States and other countries around the world. Get the most recent company news and stock data here >>

Downgrades

Agrium (NYSE:AGU): RBC Capital Mkts downgraded its rating on this company from Outperform to Sector Perform and changed its price target from $90 to $75. About the company: Agrium Inc. supplies nitrogen, potash and phosphate for agricultural, industrial, and specialty use. The Company operates throughout the America’s while it markets its products globally. Get the most recent company news and stock data here >>

KB Home (NYSE:KBH): Stifel Nicolaus downgraded its rating on this company from Buy to Hold. About the company: KB HOME builds single-family homes in the United States, primarily targeting first-time and first move-up homebuyers. The Company has operating divisions in Arizona, California, Colorado, Florida, Georgia, Illinois, Nevada, Wisconsin, New Mexico, North Carolina, South Carolina, and Texas in the United States. KB Home also derives income from mortgage banking, title and insurance services. Get the most recent company news and stock data here >>

Manhattan Assoc (NASDAQ:MANH): The Benchmark Company downgraded its rating on this company from Buy to Hold. About the company: Manhattan Associates, Inc. provides information technology solutions for distribution centers. The solutions are designed to enable the efficient movement of goods through the supply chain. The Company’s solutions optimize the receipt, storage, and distribution of inventory, as well as manage equipment and personnel within a distribution center. Get the most recent company news and stock data here >>

Boston Scientific (NYSE:BSX): Mizuho downgraded its rating on this company from Buy to Neutral and changed its price target from $7 to $5.4. About the company: Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company’s products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>